Pooled Safety Analysis from Phase I-III Studies for Patients with Hematological Malignancies Treated with the PI3K Inhibitor Copanlisib

Autor: Zinzani, Pier Luigi, Özcan, Muhit, Capra, Marcelo, Santoro, Armando *, Panayiotidis, Panayiotis, Bouabdallah, Krimo *, Jurczak, Wojciech, Phelps, Charles *, Hiemeyer, Florian JR *, Mongay Soler, Lidia *, Garcia-Vargas, Jose *, Childs, Barrett H., Lenz, Georg, Matasar, Matthew J., Dreyling, Martin
Zdroj: In Blood 15 November 2022 140 Supplement 1:6470-6473
Databáze: ScienceDirect